Marta Jakubaszek

Marta Jakubaszek

Auto-generated profile, based on publicly available information

Marta Jakubaszek

Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemical Biology, 75005, Paris, France

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2020 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JKJohannes Karges
Johannes Karges
FHFranz Heinemann
Franz Heinemann
MJMarta Jakubaszek
Marta Jakubaszek
FMFederica Maschietto
Federica Maschietto
CSChloé Subecz
Chloé Subecz
Gilles GasserGilles Gasser
Gilles Gasser

23 October 2018 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
MJMarta Jakubaszek
Marta Jakubaszek
Bruno GoudBruno Goud
Bruno Goud
SFStefano Ferrari
Stefano Ferrari
Gilles GasserGilles Gasser
Gilles Gasser
This feature article provides an overview of the most in-depth biological studies on Ru( ii ) polypyridyl complexes upon light activation.

28 February 2020 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
ANAnna Notaro
Anna Notaro
MJMarta Jakubaszek
Marta Jakubaszek
NRNils Rotthowe
Nils Rotthowe
FMFederica Maschietto
Federica Maschietto
RVRobin Vinck
Robin Vinck
Gilles GasserGilles Gasser
Gilles Gasser

30 January 2020 in Chemical Science
Verified
Journal Article
Open access
PDF file
NSNancy Soliman
Nancy Soliman
LLuke Mckenzie
Luke Mckenzie
JKJohannes Karges
Johannes Karges
EBEmilie Bertrand
Emilie Bertrand
MTMickaël Tharaud
Mickaël Tharaud
CTChristophe M. Thomas
Christophe M. Thomas
Ruthenium complexes have attracted a lot of attention as potential photosensitizers (PSs) for photodynamic therapy (PDT). However, some of these PSs are unsuitable for PDT applications due to their low cellular uptake, which is possibly the consequence of their relatively low degree of lipophilicity, which prevents them from penetrating into tumor cells. Here, we report the simple one-pot synthesis of ruthenium-containing nanoconjugates from a non-cell-penetrating, non-phototoxic ruthenium(II) polypyridyl complex (RuOH), by a drug-initiated ring-opening polymerization of lactide through the formation of a zinc initiator. These conjugates were then formulated into nanoparticles by nanoprecipitation and characterized by means of nuclear magnetic resonance spectroscopy (NMR), matrix-assisted laser desorption/ionization – time of flight mass spectrometry (MALDI-TOF MS) and dynamic light scattering (DLS). Finally, their photo-therapeutic activity (λexc = 480 nm, 3.21 J cm−2) in cancerous human cervical carcinoma (HeLa) and non-cancerous retinal pigment epithelium (RPE-1) cells was tested alongside that of RuOH and their cellular uptake in HeLa cells was assessed by confocal microscopy and inductively coupled plasma – mass spectrometry (ICP-MS). All nanoparticles showed improved photophysical properties including luminescence and singlet oxygen generation, enhanced cellular uptake and, capitalizing on this, an improved photo-toxicity. Overall, this study demonstrates how it is possible to transform a non-phototoxic PDT PS into an active PS using an easy, versatile polymerization technique.

24 July 2019 in ChemBioChem
Verified
Journal Article
Open access
PDF file
JKJohannes Karges
Johannes Karges
MJMarta Jakubaszek
Marta Jakubaszek
CMCristina Mari
Cristina Mari
KZKristof Zarschler
Kristof Zarschler
Bruno GoudBruno Goud
Bruno Goud
Gilles GasserGilles Gasser
Gilles Gasser
There is a current surge of interest in the development of novel photosensitizers (PSs) for photodynamic therapy (PDT), as those currently approved are not completely ideal. Among the tested compounds, we have previously investigated the use of RuII polypyridyl complexes with a [Ru(bipy)2(dppz)]2+ and [Ru(phen)2(dppz)]2+ scaffold (bipy=2,2′‐bipyridine; dppz=dipyrido[3,2‐a:2′,3′‐c]phenazine; phen=1,10‐phenanthroline). These complexes selectively target DNA. However, because DNA is ubiquitous, it would be of great interest to increase the selectivity of our PDT PSs by linking them to a targeting vector in view of targeted PDT. Herein, we present the synthesis, characterization, and in‐depth photophysical evaluation of a nanobody‐containing RuII polypyridyl conjugate selective for the epidermal growth factor receptor (EGFR) in view of targeted PDT. Using ICP‐MS and confocal microscopy, we could demonstrate that our conjugate has high selectivity for the EGFR receptor, which is a crucial oncological target because it is overexpressed and/or deregulated in a variety of solid tumors. However, in contrast to expectations, this conjugate was found to not produce reactive oxygen species (ROS) in cancer cells and is therefore not phototoxic.

22 April 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ANAnna Notaro
Anna Notaro
AFAngelo Frei
Angelo Frei
RRRiccardo Rubbiani
Riccardo Rubbiani
MJMarta Jakubaszek
Marta Jakubaszek
UBUttara Basu
Uttara Basu
Gilles GasserGilles Gasser
Gilles Gasser